TTR Gene Silencers for Hereditary ATTR Amyloidosis: More than ICER Recognized.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30589634.
- Also identified by DOI 10.18553/jmcp.2019.25.1.015 and PMC identifier 10398315.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No funding support was received for the writing of this commentary. The author ser ves as a consultant for Akcea Therapeutics, Alnylam Phar maceuticals, Corino Therapeutics, Intellia Therapeutics, and Ionis Pharmaceuticals.
Medical subject headings
- Amyloid Neuropathies, Familial
- Genetic Therapy
- Oligodeoxyribonucleotides, Antisense
- Prealbumin
- Quality-Adjusted Life Years